Harris Matthew Scott 4
4 · Altimmune, Inc. · Filed Aug 1, 2024
Insider Transaction Report
Form 4
Harris Matthew Scott
Chief Medical Officer
Transactions
- Award
Common Stock, par value $0.0001
2024-07-31$5.41/sh+1,486$8,039→ 55,119 total
Footnotes (2)
- [F1]These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2024 through July 31, 2024.
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2024.